FDA Issues Draft Guidance to Cut Unnecessary Animal Testing for Cancer Drugs

摘要

The U.S. Food and Drug Administration today issued a draft guidance to reduce unnecessary animal testing in nonclinical safety assessments for certain cancer drugs.